Frontier Medicines Expands Leadership Team with Addition of Christo Shalish as Head of Business Development
February 28, 2023
Frontier Medicines Announces Advancement of Second and Third Programs Under Global Partnership with AbbVie
January 5, 2023
Frontier Medicines Announces Appointment of Accomplished Finance and Operations Executive, Setareh “SiSi” Pouraghabagher, to Board of Directors
November 8, 2022
Frontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General Counsel
August 25, 2022
Frontier Medicines Announces Distinguished Oncologist Dr. Pasi Jänne Joins its Scientific Advisory Board
July 14, 2022
Frontier Medicines Announces Prominent Oncologist Dr. Scott Kopetz Joins its Scientific Advisory Board
June 21, 2022